Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells-Reference-Cited by-同舟云学术

Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells

Published:2022-05 Issue:5 Volume:40 Page:545-557.e13
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Anadon Carmen M.^ORCID,Yu Xiaoqing^ORCID,Hänggi Kay,Biswas Subir^ORCID,Chaurio Ricardo A.^ORCID,Martin Alexandra^ORCID,Payne Kyle K.^ORCID,Mandal Gunjan^ORCID,Innamarato Patrick,Harro Carly M.,Mine Jessica A.^ORCID,Sprenger Kimberly B.^ORCID,Cortina Carla,Powers John J.^ORCID,Costich Tara Lee,Perez Bradford A.,Gatenbee Chandler D.^ORCID,Prabhakaran Sandhya^ORCID,Marchion Douglas,Heemskerk Mirjam H.M.^ORCID,Curiel Tyler J.,Anderson Alexander R.^ORCID,Wenham Robert M.,Rodriguez Paulo C.^ORCID,Conejo-Garcia Jose R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference83 articles.

1. SCENIC: single-cell regulatory network inference and clustering;Aibar;Nat. Methods,2017

2. Tissue-resident memory T cells at the center of immunity to solid tumors;Amsen;Nat. Immunol.,2018

3. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium;Ashburner;Nat. Genet.,2000

4. Spatstat: an R package for analyzing spatial point patterns;Baddeley;J. Stat. Softw.,2005

5. Modelling spatial point patterns in R;Baddeley,2006

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer;Neoplasia;2024-11

2. Immune escape between endoplasmic reticulum stress-related cancer cells and exhausted CD8+T cells leads to neoadjuvant chemotherapy resistance in ovarian cancer;Biochemical and Biophysical Research Communications;2024-11

3. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

4. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09

5. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach;Nature Reviews Clinical Oncology;2024-09-04